Cargando…

Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise

INTRODUCTION: Immunoglobulin G (IgG) contains a conserved N-glycan in the fragment crystallizable (Fc), modulating its structure and effector functions. In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) alterations of IgG Fc-glycosylation have been observed to correlate with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojcik, Iwona, Wuhrer, Manfred, Heeringa, Peter, Stegeman, Coen A., Rutgers, Abraham, Falck, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570725/
https://www.ncbi.nlm.nih.gov/pubmed/37841251
http://dx.doi.org/10.3389/fimmu.2023.1214945
_version_ 1785119833560449024
author Wojcik, Iwona
Wuhrer, Manfred
Heeringa, Peter
Stegeman, Coen A.
Rutgers, Abraham
Falck, David
author_facet Wojcik, Iwona
Wuhrer, Manfred
Heeringa, Peter
Stegeman, Coen A.
Rutgers, Abraham
Falck, David
author_sort Wojcik, Iwona
collection PubMed
description INTRODUCTION: Immunoglobulin G (IgG) contains a conserved N-glycan in the fragment crystallizable (Fc), modulating its structure and effector functions. In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) alterations of IgG Fc-glycosylation have been observed to correlate with the disease course. Here, we examined longitudinal changes in N-linked Fc glycans of IgG in an AAV patient cohort and their relationship with disease flares. METHODS: Using liquid chromatography coupled with mass spectrometry, we analysed IgG Fc-glycosylation in 410 longitudinal samples from 96 individuals with AAV. RESULTS: Analysis of the cross-sectional differences as well as longitudinal changes demonstrated that IgGs of relapsing PR3-ANCA patients have higher ΔFc-bisection at diagnosis (P = 0.004) and exhibit a decrease in Fc-sialylation prior to the relapse (P = 0.0004), discriminating them from non-relapsing patients. Most importantly, PR3-ANCA patients who experienced an ANCA rise and relapsed shortly thereafter, exhibit lower IgG Fc-fucosylation levels compared to non-relapsing patients already 9 months before relapse (P = 0.02). DISCUSSION: Our data indicate that IgG Fc-bisection correlates with long-term treatment outcome, while lower IgG Fc-fucosylation and sialylation associate with impending relapse. Overall, our study replicated the previously published reduction in total IgG Fc-sialylation at the time of relapse, but showed additionally that its onset precedes relapse. Furthermore, our findings on IgG fucosylation and bisection are entirely new. All these IgG Fc-glycosylation features may have the potential to predict a relapse either independently or in combination with known risk factors, such as a rise in ANCA titre.
format Online
Article
Text
id pubmed-10570725
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105707252023-10-14 Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise Wojcik, Iwona Wuhrer, Manfred Heeringa, Peter Stegeman, Coen A. Rutgers, Abraham Falck, David Front Immunol Immunology INTRODUCTION: Immunoglobulin G (IgG) contains a conserved N-glycan in the fragment crystallizable (Fc), modulating its structure and effector functions. In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) alterations of IgG Fc-glycosylation have been observed to correlate with the disease course. Here, we examined longitudinal changes in N-linked Fc glycans of IgG in an AAV patient cohort and their relationship with disease flares. METHODS: Using liquid chromatography coupled with mass spectrometry, we analysed IgG Fc-glycosylation in 410 longitudinal samples from 96 individuals with AAV. RESULTS: Analysis of the cross-sectional differences as well as longitudinal changes demonstrated that IgGs of relapsing PR3-ANCA patients have higher ΔFc-bisection at diagnosis (P = 0.004) and exhibit a decrease in Fc-sialylation prior to the relapse (P = 0.0004), discriminating them from non-relapsing patients. Most importantly, PR3-ANCA patients who experienced an ANCA rise and relapsed shortly thereafter, exhibit lower IgG Fc-fucosylation levels compared to non-relapsing patients already 9 months before relapse (P = 0.02). DISCUSSION: Our data indicate that IgG Fc-bisection correlates with long-term treatment outcome, while lower IgG Fc-fucosylation and sialylation associate with impending relapse. Overall, our study replicated the previously published reduction in total IgG Fc-sialylation at the time of relapse, but showed additionally that its onset precedes relapse. Furthermore, our findings on IgG fucosylation and bisection are entirely new. All these IgG Fc-glycosylation features may have the potential to predict a relapse either independently or in combination with known risk factors, such as a rise in ANCA titre. Frontiers Media S.A. 2023-09-29 /pmc/articles/PMC10570725/ /pubmed/37841251 http://dx.doi.org/10.3389/fimmu.2023.1214945 Text en Copyright © 2023 Wojcik, Wuhrer, Heeringa, Stegeman, Rutgers and Falck https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wojcik, Iwona
Wuhrer, Manfred
Heeringa, Peter
Stegeman, Coen A.
Rutgers, Abraham
Falck, David
Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
title Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
title_full Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
title_fullStr Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
title_full_unstemmed Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
title_short Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
title_sort specific igg glycosylation differences precede relapse in pr3-anca associated vasculitis patients with and without anca rise
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570725/
https://www.ncbi.nlm.nih.gov/pubmed/37841251
http://dx.doi.org/10.3389/fimmu.2023.1214945
work_keys_str_mv AT wojcikiwona specificiggglycosylationdifferencesprecederelapseinpr3ancaassociatedvasculitispatientswithandwithoutancarise
AT wuhrermanfred specificiggglycosylationdifferencesprecederelapseinpr3ancaassociatedvasculitispatientswithandwithoutancarise
AT heeringapeter specificiggglycosylationdifferencesprecederelapseinpr3ancaassociatedvasculitispatientswithandwithoutancarise
AT stegemancoena specificiggglycosylationdifferencesprecederelapseinpr3ancaassociatedvasculitispatientswithandwithoutancarise
AT rutgersabraham specificiggglycosylationdifferencesprecederelapseinpr3ancaassociatedvasculitispatientswithandwithoutancarise
AT falckdavid specificiggglycosylationdifferencesprecederelapseinpr3ancaassociatedvasculitispatientswithandwithoutancarise